ARCA biopharma Inc (ABIO)
3.715
+0.26
(+7.68%)
USD |
NASDAQ |
Apr 23, 14:56
ARCA biopharma Cash from Operations (TTM): -5.014M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.014M |
| September 30, 2023 | -5.452M |
| June 30, 2023 | -6.281M |
| March 31, 2023 | -8.209M |
| December 31, 2022 | -10.91M |
| September 30, 2022 | -14.36M |
| June 30, 2022 | -16.74M |
| March 31, 2022 | -17.84M |
| December 31, 2021 | -18.76M |
| September 30, 2021 | -16.81M |
| June 30, 2021 | -13.94M |
| March 31, 2021 | -11.26M |
| December 31, 2020 | -7.725M |
| September 30, 2020 | -5.888M |
| June 30, 2020 | -4.773M |
| March 31, 2020 | -4.921M |
| December 31, 2019 | -4.801M |
| September 30, 2019 | -4.986M |
| June 30, 2019 | -5.675M |
| March 31, 2019 | -6.739M |
| December 31, 2018 | -8.244M |
| September 30, 2018 | -11.10M |
| June 30, 2018 | -13.50M |
| March 31, 2018 | -16.20M |
| December 31, 2017 | -17.47M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.12M |
| June 30, 2017 | -16.88M |
| March 31, 2017 | -15.45M |
| December 31, 2016 | -14.99M |
| September 30, 2016 | -13.76M |
| June 30, 2016 | -12.43M |
| March 31, 2016 | -11.30M |
| December 31, 2015 | -10.53M |
| September 30, 2015 | -9.793M |
| June 30, 2015 | -9.468M |
| March 31, 2015 | -8.832M |
| December 31, 2014 | -9.406M |
| September 30, 2014 | -9.399M |
| June 30, 2014 | -8.998M |
| March 31, 2014 | -8.211M |
| December 31, 2013 | -5.288M |
| September 30, 2013 | -4.086M |
| June 30, 2013 | -3.185M |
| March 31, 2013 | -3.186M |
| December 31, 2012 | -4.078M |
| September 30, 2012 | -4.644M |
| June 30, 2012 | -5.545M |
| March 31, 2012 | -6.675M |
| December 31, 2011 | -6.959M |
| September 30, 2011 | -6.865M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-18.76M
Minimum
Dec 2021
-4.773M
Maximum
Jun 2020
-9.703M
Average
-7.725M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
| Shockwave Medical Inc | 196.05M |
| Asensus Surgical Inc | -63.63M |
| Glaukos Corp | -57.76M |
| Helius Medical Technologies Inc | -10.42M |
| Perspective Therapeutics Inc | -36.91M |